Email This

Your Name

Recipient's Email

Subject

Results of a systematic review and meta-analysis of more than 2000 patients show a 26% prevalence of new-onset non-alcoholic fatty liver disease (NAFLD) in patients who have undergone a liver transplant compared to the 22% prevalence in the general population. These findings are published in the journal Alimentary Pharmacology & Therapeutics.

Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.

Results of a systematic review and meta-analysis of more than 2000 patients show a 26% prevalence of new-onset non-alcoholic fatty liver disease (NAFLD) in patients who have undergone a liver transplant compared to the 22% prevalence in the general population. These findings are published in the journal Alimentary Pharmacology & Therapeutics.